Exponent, Inc. $EXPO Shares Sold by Tudor Investment Corp ET AL

Key Points

• Tudor Investment Corp cut its stake in Exponent by 67.6% in Q3, selling 39,556 shares and ending the period with 18,916 shares worth $1.314 million.
• Exponent beat quarterly estimates, reporting EPS of $0.49 vs. $0.47 expected and revenue of $147.43M (vs. $128.48M), with revenue up 4.5% year-over-year.
• Insiders have been selling: CEO Catherine Corrigan sold 3,920 shares and VP John Pye sold 4,000, with a total of 9,583 insider shares sold in the last three months worth $687,709; insiders now own 1.6% of the company.

Tudor Investment Corp ET AL cut its holdings in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 67.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,916 shares of the business services provider's stock after selling 39,556 shares during the period. Tudor Investment Corp ET AL's holdings in Exponent were worth $1,314,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Hantz Financial Services Inc. raised its stake in Exponent by 97.0% in the third quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider's stock valued at $28,000 after buying an additional 195 shares in the last quarter. Aster Capital Management DIFC Ltd acquired a new stake in Exponent in the third quarter valued at $33,000. Winnow Wealth LLC acquired a new stake in Exponent in the third quarter valued at $34,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in Exponent in the third quarter valued at $38,000. Finally, UMB Bank n.a. raised its stake in Exponent by 145.4% in the third quarter. UMB Bank n.a. now owns 584 shares of the business services provider's stock valued at $41,000 after buying an additional 346 shares in the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Exponent Stock Performance

Shares of EXPO stock opened at $66.61 on Tuesday. The stock's 50-day moving average is $69.01 and its two-hundred day moving average is $70.35. The firm has a market cap of $3.28 billion, a price-to-earnings ratio of 32.02 and a beta of 0.80. Exponent, Inc. has a 1 year low of $63.25 and a 1 year high of $83.92.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The business services provider reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.02. Exponent had a return on equity of 25.51% and a net margin of 18.21%.The company had revenue of $147.43 million for the quarter, compared to analyst estimates of $128.48 million. During the same quarter last year, the company posted $0.46 earnings per share. The business's quarterly revenue was up 4.5% compared to the same quarter last year. As a group, research analysts predict that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Friday, March 6th were issued a dividend of $0.31 per share. This is an increase from Exponent's previous quarterly dividend of $0.30. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend was Friday, March 6th. Exponent's dividend payout ratio is 59.62%.

Insider Transactions at Exponent

In related news, CEO Catherine Corrigan sold 3,920 shares of the firm's stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $67.15, for a total transaction of $263,228.00. Following the transaction, the chief executive officer owned 93,731 shares of the company's stock, valued at $6,294,036.65. This trade represents a 4.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP John Pye sold 4,000 shares of the firm's stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $75.97, for a total value of $303,880.00. Following the transaction, the vice president directly owned 25,204 shares in the company, valued at approximately $1,914,747.88. This represents a 13.70% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 9,583 shares of company stock worth $687,709. Corporate insiders own 1.60% of the company's stock.

Wall Street Analysts Forecast Growth

EXPO has been the topic of a number of analyst reports. JPMorgan Chase & Co. cut their price target on Exponent from $100.00 to $95.00 and set an "overweight" rating on the stock in a research note on Thursday, March 26th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Exponent in a report on Thursday, January 22nd. Finally, UBS Group reaffirmed a "neutral" rating and set a $85.00 price objective on shares of Exponent in a report on Monday, February 9th. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $90.00.

Exponent Profile

Exponent, Inc NASDAQ: EXPO is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company's expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.